Retained Earnings - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33%
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epizyme Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Retained Earnings
-$1.3B
CAGR 3-Years
-26%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$3.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
$11.2B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$27.1B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-17%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
$7.6B
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$29.4B
CAGR 3-Years
25%
CAGR 5-Years
38%
CAGR 10-Years
84%

See Also

What is Epizyme Inc's Retained Earnings?
Retained Earnings
-1.3B USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Retained Earnings amounts to -1.3B USD.

What is Epizyme Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-26%

Over the last year, the Retained Earnings growth was -18%. The average annual Retained Earnings growth rates for Epizyme Inc have been -26% over the past three years , -26% over the past five years .

Back to Top